Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
CNY 16.2
(1.31%)
CNY 16.2
(1.31%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 361.82 Million CNY | 286.54% |
| 2022 | 93.6 Million CNY | -23.34% |
| 2021 | 122.1 Million CNY | 1317.31% |
| 2020 | 8.61 Million CNY | -95.42% |
| 2019 | 188.13 Million CNY | 1.71% |
| 2018 | 184.97 Million CNY | 58.35% |
| 2017 | 116.81 Million CNY | 1.05% |
| 2016 | 115.6 Million CNY | 1.22% |
| 2015 | 114.21 Million CNY | 22.97% |
| 2014 | 92.88 Million CNY | -68.84% |
| 2013 | 298.05 Million CNY | 0.32% |
| 2012 | 297.1 Million CNY | -8.52% |
| 2011 | 324.76 Million CNY | 59.67% |
| 2010 | 203.39 Million CNY | 31.64% |
| 2009 | 154.5 Million CNY | 17.04% |
| 2008 | 132 Million CNY | -0.33% |
| 2007 | 132.44 Million CNY | 32.15% |
| 2006 | 100.22 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 59.15 Million CNY | 208.72% |
| 2024 Q2 | 43.19 Million CNY | -26.97% |
| 2024 Q3 | 66.89 Million CNY | 54.86% |
| 2023 Q4 | 19.16 Million CNY | -92.41% |
| 2023 FY | 361.82 Million CNY | 286.54% |
| 2023 Q1 | 46.5 Million CNY | 344.52% |
| 2023 Q2 | 43.68 Million CNY | -6.06% |
| 2023 Q3 | 252.48 Million CNY | 478.01% |
| 2022 Q1 | 41.95 Million CNY | 72.02% |
| 2022 FY | 93.6 Million CNY | -23.34% |
| 2022 Q4 | -19.01 Million CNY | -146.76% |
| 2022 Q3 | 40.66 Million CNY | 35.57% |
| 2022 Q2 | 29.99 Million CNY | -28.49% |
| 2021 Q1 | 36.05 Million CNY | 151.1% |
| 2021 Q2 | 25.19 Million CNY | -30.11% |
| 2021 Q3 | 36.46 Million CNY | 44.71% |
| 2021 Q4 | 24.38 Million CNY | -33.12% |
| 2021 FY | 122.1 Million CNY | 1317.31% |
| 2020 Q1 | 34.25 Million CNY | -35.82% |
| 2020 Q2 | 22.31 Million CNY | -34.85% |
| 2020 Q3 | 22.6 Million CNY | 1.29% |
| 2020 Q4 | -70.55 Million CNY | -412.16% |
| 2020 FY | 8.61 Million CNY | -95.42% |
| 2019 Q4 | 53.37 Million CNY | 16.26% |
| 2019 Q1 | 44.42 Million CNY | -44.48% |
| 2019 FY | 188.13 Million CNY | 1.71% |
| 2019 Q3 | 45.9 Million CNY | 3.33% |
| 2019 Q2 | 44.42 Million CNY | 0.01% |
| 2018 Q4 | 80.02 Million CNY | 121.3% |
| 2018 FY | 184.97 Million CNY | 58.35% |
| 2018 Q3 | 36.15 Million CNY | 29.75% |
| 2018 Q2 | 27.86 Million CNY | -31.91% |
| 2018 Q1 | 40.92 Million CNY | 143.38% |
| 2017 FY | 116.81 Million CNY | 1.05% |
| 2017 Q1 | 40.7 Million CNY | 11.28% |
| 2017 Q3 | 21.61 Million CNY | -42.62% |
| 2017 Q4 | 16.81 Million CNY | -22.21% |
| 2017 Q2 | 37.67 Million CNY | -7.46% |
| 2016 FY | 115.6 Million CNY | 1.22% |
| 2016 Q1 | 42.68 Million CNY | 945.7% |
| 2016 Q3 | 9.74 Million CNY | -63.36% |
| 2016 Q2 | 26.59 Million CNY | -37.71% |
| 2016 Q4 | 36.58 Million CNY | 275.44% |
| 2015 FY | 114.21 Million CNY | 22.97% |
| 2015 Q2 | 59.55 Million CNY | 26.95% |
| 2015 Q3 | 12.78 Million CNY | -78.53% |
| 2015 Q4 | -5.04 Million CNY | -139.48% |
| 2015 Q1 | 46.91 Million CNY | 412.25% |
| 2014 Q2 | 29.61 Million CNY | -54.63% |
| 2014 Q4 | -15.02 Million CNY | -215.33% |
| 2014 Q3 | 13.02 Million CNY | -56.01% |
| 2014 Q1 | 65.26 Million CNY | 145.92% |
| 2014 FY | 92.88 Million CNY | -68.84% |
| 2013 Q3 | 62 Million CNY | -39.69% |
| 2013 Q2 | 102.8 Million CNY | -3.65% |
| 2013 FY | 298.05 Million CNY | 0.32% |
| 2013 Q4 | 26.54 Million CNY | -57.2% |
| 2013 Q1 | 106.7 Million CNY | 348.43% |
| 2012 Q1 | 100.23 Million CNY | 160.09% |
| 2012 Q4 | 23.79 Million CNY | -65.59% |
| 2012 Q3 | 69.15 Million CNY | -33.46% |
| 2012 Q2 | 103.92 Million CNY | 3.68% |
| 2012 FY | 297.1 Million CNY | -8.52% |
| 2011 Q2 | 72.09 Million CNY | -57.0% |
| 2011 Q1 | 167.65 Million CNY | 693.12% |
| 2011 Q4 | 38.53 Million CNY | -17.08% |
| 2011 FY | 324.76 Million CNY | 59.67% |
| 2011 Q3 | 46.47 Million CNY | -35.53% |
| 2010 Q2 | 58.82 Million CNY | -19.87% |
| 2010 FY | 203.39 Million CNY | 31.64% |
| 2010 Q3 | 50.01 Million CNY | -14.98% |
| 2010 Q4 | 21.13 Million CNY | -57.73% |
| 2010 Q1 | 73.41 Million CNY | 641.49% |
| 2009 Q4 | 9.9 Million CNY | -69.08% |
| 2009 Q1 | 59.78 Million CNY | 0.0% |
| 2009 Q2 | 52.79 Million CNY | -11.69% |
| 2009 FY | 154.5 Million CNY | 17.04% |
| 2009 Q3 | 32.02 Million CNY | -39.35% |
| 2008 FY | 132 Million CNY | -0.33% |
| 2007 FY | 132.44 Million CNY | 32.15% |
| 2006 FY | 100.22 Million CNY | 0.0% |